Your browser is no longer supported. Please, upgrade your browser.
Settings
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E33.56 EPS (ttm)6.68 Insider Own11.60% Shs Outstand908.80M Perf Week10.92%
Market Cap215.63B Forward P/E26.02 EPS next Y8.61 Insider Trans-1.52% Shs Float857.17M Perf Month15.99%
Income6.09B PEG2.65 EPS next Q1.93 Inst Own83.90% Short Float0.89% Perf Quarter7.69%
Sales25.49B P/S8.46 EPS this Y36.90% Inst Trans0.45% Short Ratio2.07 Perf Half Y41.83%
Book/sh7.59 P/B29.52 EPS next Y8.72% ROA13.60% Target Price213.73 Perf Year55.53%
Cash/sh3.17 P/C70.67 EPS next 5Y12.67% ROE113.60% 52W Range129.21 - 235.85 Perf YTD32.72%
Dividend3.40 P/FCF60.00 EPS past 5Y24.60% ROI22.60% 52W High-4.99% Beta0.25
Dividend %1.52% Quick Ratio1.10 Sales past 5Y4.20% Gross Margin75.90% 52W Low73.43% ATR6.46
Employees35000 Current Ratio1.40 Sales Q/Q16.10% Oper. Margin22.10% RSI (14)69.05 Volatility5.73% 2.84%
OptionableYes Debt/Eq2.35 EPS Q/Q-7.00% Profit Margin23.90% Rel Volume1.53 Prev Close233.54
ShortableYes LT Debt/Eq2.35 EarningsApr 27 BMO Payout45.70% Avg Volume3.67M Price224.09
Recom2.10 SMA209.78% SMA5015.57% SMA20028.49% Volume5,621,573 Change-4.05%
Jan-19-21Upgrade Mizuho Neutral → Buy $164 → $222
Dec-10-20Upgrade Wolfe Research Peer Perform → Outperform $147 → $183
Nov-10-20Resumed Bernstein Mkt Perform $150
Sep-29-20Initiated Berenberg Hold $144
Sep-03-20Upgrade Morgan Stanley Equal-Weight → Overweight $176
Jun-16-20Upgrade Guggenheim Neutral → Buy
Apr-21-20Downgrade UBS Buy → Neutral $157 → $158
Apr-09-20Downgrade Morgan Stanley Overweight → Equal-Weight $148
Feb-06-20Initiated Mizuho Neutral
Dec-18-19Upgrade Morgan Stanley Equal-Weight → Overweight $116 → $150
Oct-17-19Resumed BofA/Merrill Buy $133
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Jun-11-21 02:23PM  
01:00PM  
08:41AM  
Jun-10-21 04:19PM  
02:11PM  
Jun-09-21 08:28AM  
Jun-08-21 10:47AM  
10:09AM  
08:24AM  
07:12AM  
Jun-07-21 04:15PM  
03:51PM  
11:25AM  
08:50AM  
08:49AM  
08:34AM  
Jun-04-21 05:50PM  
03:37PM  
09:00AM  
Jun-03-21 10:00AM  
06:45AM  
Jun-02-21 12:06PM  
06:00AM  
01:44AM  
Jun-01-21 07:30PM  
07:01PM  
May-29-21 09:27AM  
May-28-21 02:18PM  
10:44AM  
10:17AM  
May-27-21 03:40PM  
02:50PM  
12:10PM  
11:53AM  
11:31AM  
09:04AM  
07:44AM  
07:17AM  
07:10AM  
May-25-21 06:37PM  
06:33AM  
12:41AM  
May-24-21 12:27PM  
08:24AM  
06:49AM  
May-22-21 12:16PM  
May-21-21 09:51AM  
08:51AM  
May-20-21 09:26AM  
06:45AM  
May-19-21 05:00PM  
09:14AM  
May-18-21 10:12AM  
06:35AM  
12:14AM  
12:09AM  
May-16-21 04:42PM  
May-14-21 04:07PM  
May-13-21 04:26PM  
10:00AM  
09:51AM  
May-11-21 09:39AM  
09:26AM  
06:45AM  
May-10-21 03:57PM  
May-09-21 11:50PM  
11:36PM  
11:36PM  
04:01AM  
May-06-21 09:32AM  
06:45AM  
05:47AM  
May-05-21 02:12PM  
02:08PM  
01:19PM  
10:00AM  
07:27AM  
07:27AM  
06:40AM  
May-04-21 03:39PM  
03:01PM  
10:07AM  
09:31AM  
07:31AM  
07:22AM  
07:00AM  
06:42AM  
06:20AM  
May-03-21 03:28PM  
10:00AM  
06:42AM  
Apr-30-21 11:24AM  
Apr-29-21 11:40AM  
Apr-28-21 10:19PM  
08:37AM  
Apr-27-21 04:12PM  
04:00PM  
02:34PM  
02:34PM  
11:49AM  
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products worldwide. It offers Baqsimi for severe hypoglycemia; Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500, and Lyumjev for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company also provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+ and HER2- metastatic breast cancer. In addition, it offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Further, the company Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; Reyvow for migraine; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Additionally, it Bamlanivimab and etesevimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; AbCellera Biologics Inc.; and Junshi Biosciences. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerJun 10Sale233.63240,00056,072,352109,412,100Jun 11 10:35 AM
LILLY ENDOWMENT INC10% OwnerJun 09Sale224.93220,00049,484,263109,652,100Jun 10 03:35 PM
LILLY ENDOWMENT INC10% OwnerJun 07Sale224.72230,00051,685,008109,872,100Jun 08 03:16 PM
LILLY ENDOWMENT INC10% OwnerMay 24Sale202.277,3291,482,405110,102,100May 25 10:39 AM
LILLY ENDOWMENT INC10% OwnerMay 21Sale200.5892,74018,602,006110,109,429May 24 11:15 AM
LILLY ENDOWMENT INC10% OwnerMay 20Sale200.4899,93120,033,767110,202,169May 21 12:57 PM
TAI JACKSON PDirectorApr 30Buy182.841,366249,75961,195May 03 07:01 PM
Zakrowski Donald AChief Accounting OfficerApr 28Sale181.383,000544,1405,987Apr 29 08:31 PM
LILLY ENDOWMENT INC10% OwnerMar 09Sale209.7959,95912,579,032110,302,100Mar 10 02:59 PM
LILLY ENDOWMENT INC10% OwnerMar 08Sale209.69125,28426,271,092110,362,059Mar 09 12:26 PM
Hakim AnatSVP, GC & SecretaryMar 01Option Exercise0.007,92807,928Mar 03 05:19 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.005,445027,425Feb 03 06:29 PM
Shah Aarti S.SVP & CIDOFeb 01Option Exercise0.006,282023,369Feb 03 07:02 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0075,3870343,639Feb 03 06:57 PM
Smiley Joshua LSVP and CFOFeb 01Option Exercise0.0019,266060,702Feb 03 08:22 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0016,754035,400Feb 03 07:26 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Feb 01Option Exercise0.006,282010,592Feb 03 06:51 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.0012,146056,919Feb 03 06:43 PM
Norton JohnaSenior VP, Global QualityFeb 01Option Exercise0.003,435020,953Feb 03 06:38 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0015,0780115,289Feb 03 06:33 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale190.80215,00041,022,862110,487,343Jan 19 01:04 PM
LILLY ENDOWMENT INC10% OwnerJan 13Sale185.97210,00039,053,064110,702,343Jan 14 11:23 AM
LILLY ENDOWMENT INC10% OwnerJan 11Sale185.49220,00040,807,754110,912,343Jan 12 11:27 AM
Smiley Joshua LSVP and CFOOct 01Option Exercise0.007,947044,918Oct 05 12:19 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMSep 08Sale151.015,000755,05023,580Sep 10 04:25 PM
Mason Michael BSr. VP & Pres., Lilly DiabetesSep 01Option Exercise0.006,244021,279Sep 02 05:04 PM
Fry Stephen FSVP, HR & DiversityAug 17Sale150.647,2041,085,211100,211Aug 18 03:31 PM
LILLY ENDOWMENT INC10% OwnerJul 09Sale169.6912,9612,199,392111,132,343Jul 10 02:16 PM
Zulueta Alfonso GSVP & President, Lilly Int'lJul 09Sale170.0011,0001,870,00018,646Jul 13 01:43 PM
LILLY ENDOWMENT INC10% OwnerJul 07Sale167.29210,00035,131,799111,145,304Jul 08 12:49 PM
LILLY ENDOWMENT INC10% OwnerJul 06Sale166.99205,00034,232,086111,379,612Jul 07 02:27 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,46805,424Jul 06 04:50 PM
LILLY ENDOWMENT INC10% OwnerJun 30Sale163.20166,83227,227,760111,560,304Jul 01 11:17 AM
LILLY ENDOWMENT INC10% OwnerJun 29Sale163.3911,4311,867,760111,727,136Jun 30 03:12 PM
LILLY ENDOWMENT INC10% OwnerJun 26Sale163.0131,7375,173,404111,738,567Jul 01 09:55 AM
LILLY ENDOWMENT INC10% OwnerJun 26Sale163.0131,7375,173,404111,738,567Jun 30 02:48 PM
LILLY ENDOWMENT INC10% OwnerJun 18Sale161.5453,7708,686,046111,770,304Jun 19 02:21 PM
LILLY ENDOWMENT INC10% OwnerJun 17Sale161.38161,23026,019,469111,824,074Jun 18 05:16 PM
Zulueta Alfonso GSVP & President, Lilly Int'lJun 16Sale162.9417,0002,770,00029,646Jun 18 09:36 AM
LILLY ENDOWMENT INC10% OwnerJun 16Sale162.92212,33734,593,145111,985,304Jun 17 03:13 PM